AHL
ADMA icon

Abel Hall LLC’s ADMA Biologics ADMA Stock Holding History

Abel Hall LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+23,918
New +$218K 0.03% 744
2026
Q1 		– Sell
-19,884
Closed -$363K – 816
2025
Q4 		$363K Buy
+19,884
New +$335K 0.08% 253

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Abel Hall LLC's ADMA Position: Q2 2026 in Review

Abel Hall LLC opened a new position in ADMA Biologics (ADMA) in Q2 2026: 23,918 shares worth $200K. The stake represents 0.03% of the portfolio and ranks #744 among its holdings. This is a return to the name: Abel Hall LLC previously reported a position in ADMA as recently as Q4 2025.

Abel Hall LLC first reported a position in ADMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $363K in Q4 2025. 69 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Abel Hall LLC held 23,918 shares of ADMA Biologics worth $200K as of Q2 2026.
  • ADMA Biologics was a new Abel Hall LLC position in Q2 2026.
  • ADMA Biologics made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #744 holding.
  • Abel Hall LLC first reported a position in ADMA Biologics in Q4 2025 and has held it in 2 quarters since.
  • Abel Hall LLC's ADMA Biologics position peaked at $363K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.